Sugi Predict

Sugi Predict / Compounds / Methionine Sulfoxide

Methionine Sulfoxide

Methionine Sulfoxide

SCHEMBL995666

C[S+]([O-])CCC(N)C(=O)O

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSR P00390 2/20 0.46
▸ GRM8 O00222 1/20 0.46
▸ GRM6 O15303 1/20 0.46
▸ GRIN2D O15399 1/20 0.46
▸ GRIN3B O60391 1/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ GRIK1 P39086 1/20 0.46
▸ GRM5 P41594 1/20 0.46
▸ GRIA1 P42261 1/20 0.46
▸ GRIA2 P42262 1/20 0.46
▸ GRIA3 P42263 1/20 0.46
▸ SLC1A3 P43003 1/20 0.46
▸ SLC1A2 P43004 1/20 0.46
▸ SLC1A1 P43005 1/20 0.46
▸ GRIA4 P48058 1/20 0.46
▸ GRIN1 Q05586 1/20 0.46
▸ GRIN2A Q12879 1/20 0.46
▸ GRIK2 Q13002 1/20 0.46
▸ GRIK3 Q13003 1/20 0.46
▸ GRIN2B Q13224 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methionine Sulfoxide SCHEMBL38627 1.00 GSR (0.46) GSRGRM8GRM6GRIN2DGRIN3B
Methionine Sulfoxide SCHEMBL14448373 1.00 GSR (0.46) GSRGRM8GRM6GRIN2DGRIN3B
Methionine Sulfoxide SCHEMBL288041 1.00 GSR (0.46) GSRGRM8GRM6GRIN2DGRIN3B
Methionine Sulfoxide SCHEMBL689456 1.00 GSR (0.46) GSRGRM8GRM6GRIN2DGRIN3B
Methionine Sulfoxide SCHEMBL38626 1.00 GSR (0.46) GSRGRM8GRM6GRIN2DGRIN3B
Methionine Sulfoxide SCHEMBL689512 1.00 GSR (0.46) GSRGRM8GRM6GRIN2DGRIN3B
Methionine Sulfoxide SCHEMBL4418369 1.00 GSR (0.46) GSRGRM8GRM6GRIN2DGRIN3B
Methionine Sulfoxide SCHEMBL22076611 0.98 GSR (0.45) GSRGRM8GRM6GRIN2DGRIN3B
Methionine Sulfoxide SCHEMBL28993578 0.96 GGT1 (0.44) GSRGRM8GRM6GRIN2DGRIN3B
Methionine Sulfoxide SCHEMBL16176754 0.94 GSR (0.42) GSRGRM8GRM6GRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 265 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118688315-A Multichannel high-coverage synchronous quantification method for amino-containing and hydroxyl-containing compounds 复旦大学 2024-09-24 — — CN claimed
CN-116735770-A Synchronous quantitative detection method for multiple metabolites in biological sample 复旦大学 2023-09-12 — — CN claimed
CN-115236258-B Method for simultaneously determining glycine anhydride and DL-methionine sulfoxide in sample 北京百奥药业有限责任公司 2023-06-23 — — CN claimed
CN-108913747-A A kind of high density fermentation vitamin B2Method 广济药业（孟州）有限公司 2018-11-30 — — CN claimed
CN-107475344-A A kind of method that vitamin B2 is produced using fermentation of bacillus subtilis 上海希迈医药科技有限公司 2017-12-15 — — CN claimed
CN-107475142-A A kind of vitamin B2 superior strain and preparation method thereof 赤峰制药股份有限公司 2017-12-15 — — CN claimed
CN-107475240-A A kind of screening technique of vitamin B2 superior strain 上海希迈医药科技有限公司 2017-12-15 — — CN claimed
US-9689081-B2 Electroplating bath and method for producing dark chromium layers ATOTECH DEUTSCHLAND GMBH (DE) 2017-06-27 — — US claimed
EP-2705176-B1 ELECTROPLATING BATH AND METHOD FOR PRODUCING DARK CHROMIUM LAYERS ATOTECH DEUTSCHLAND GMBH (DE) 2016-04-13 — — EP claimed
US-20160068983-A1 ELECTROPLATING BATH AND METHOD FOR PRODUCING DARK CHROMIUM LAYERS ATOTECH USA, LLC 2016-03-10 — — US claimed
EP-2886683-A2 Electroplating bath and method for producing dark chromium layers ATOTECH Deutschland GmbH (DE) 2015-06-24 — — EP claimed
EP-2705176-A2 ELECTROPLATING BATH AND METHOD FOR PRODUCING DARK CHROMIUM LAYERS ATOTECH Deutschland GmbH (DE) 2014-03-12 — — EP claimed
US-20140042033-A1 ELECTROPLATING BATH AND METHOD FOR PRODUCING DARK CHROMIUM LAYERS ATOTECH DEUTSCHLAND GMBH (DE) 2014-02-13 — — US claimed
WO-2012150198-A2 ELECTROPLATING BATH AND METHOD FOR PRODUCING DARK CHROMIUM LAYERS ATOTECH DEUTSCHLAND GMBH (DE) 2012-11-08 — — WO claimed
CN-100384983-C Method for producing 5' xanthosine phosphate by using bar-shape bacterial mutable strain to ferment AJINOMOTO KK (JP) 2008-04-30 — — CN claimed
US-20030105093-A1 MTP activity-lowering compositions YANAGITA TERUYOSHI (JP) 2003-06-05 — — US claimed
CN-1362524-A Method for producing 5' xanthosine phosphate by using bar-shape bacterial mutable strain to ferment AJINOMOTO KK (JP) 2002-08-07 — — CN claimed
US-20020098552-A1 Method for producing xanthosine-5'-monophosphate by fermentation using mutant strains of Coryneform bacteria AJINOMOTO CO., INC. (JP) 2002-07-25 — — US claimed
EP-1080724-A1 MTP ACTIVITY-LOWERING COMPOSITIONS Nippon Shinyaku Co., Ltd. (JP) 2001-03-07 — — EP claimed
US-4481219-A NON-NUTRIENT AMINO ACID NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1984-11-06 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030105093-A1 MTP activity-lowering compositions MTPN, APOB, TTR GSR 255/4885GRM8 3752/4885GRM6 2674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.